NOSIP
Nitric oxide synthase-interacting protein
Also known as: CGI-25, NOSIP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y314
- Gene
- NOSIP
- Ensembl
- ENSG00000142546
- Chromosome
- 19
- Canonical length
- 301 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The protein encoded by this gene may modulate the activity and localization of nitric oxide synthase (endothelial and neuronal) and thus nitric oxide production. Alternative splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Aug 2012]
Canonical amino-acid sequenceUniProt
301 residues, UniProt reviewed canonical sequence.
>Q9Y314|NOSIP
1 MTRHGKNCTA GAVYTYHEKK KDTAASGYGT QNIRLSRDAV KDFDCCCLSL QPCHDPVVTP
61 DGYLYEREAI LEYILHQKKE IARQMKAYEK QRGTRREEQK ELQRAASQDH VRGFLEKESA
121 IVSRPLNPFT AKALSGTSPD DVQPGPSVGP PSKDKDKVLP SFWIPSLTPE AKATKLEKPS
181 RTVTCPMSGK PLRMSDLTPV HFTPLDSSVD RVGLITRSER YVCAVTRDSL SNATPCAVLR
241 PSGAVVTLEC VEKLIRKDMV DPVTGDKLTD RDIIVLQRGG TGFAGSGVKL QAEKSRPVMQ
301 ALocalizationUniProt · AlphaFold · HPA
Whether an antibody against NOSIP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 136 nTPM
Expression across tissuesHPA
Tissue
- testis: 136 nTPM
- skeletal muscle: 126 nTPM
- pancreas: 111 nTPM
- tongue: 61 nTPM
- spleen: 59 nTPM
- heart muscle: 54 nTPM
Single-cell type
- late spermatids: 1,226 nCPM
- late primary spermatocytes: 605 nCPM
- early spermatids: 346 nCPM
- pancreatic acinar cells: 295 nCPM
- esophageal apical cells: 289 nCPM
- oocytes: 193 nCPM
Immune cell
- naive CD4 T-cell: 844 nTPM
- total PBMC: 580 nTPM
- memory CD4 T-cell: 521 nTPM
- naive CD8 T-cell: 468 nTPM
- MAIT T-cell: 330 nTPM
- T-reg: 305 nTPM
Brain region
- white matter: 41 nTPM
- cerebellum: 41 nTPM
- pons: 40 nTPM
- basal ganglia: 39 nTPM
- thalamus: 39 nTPM
- medulla oblongata: 39 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.06
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.11
- DepMap mean gene effect
- -0.21
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of catalytic activity
- negative regulation of nitric-oxide synthase activity
- nitric oxide metabolic process
- regulation of nitric oxide biosynthetic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger, RING/FYVE/PHD-type
- Nitric oxide synthase-interacting protein
- Nitric oxide synthase-interacting protein, zinc-finger
- Zinc-finger of nitric oxide synthase-interacting protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NOSIP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NOSIP as an antibody target. Whether an autoantibody or antibody against NOSIP could matter depends on whether native NOSIP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NOSIP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NOSIP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...